Disc Medicine, Inc. (IRON)
61.47
-1.88
(-2.97%)
USD |
NASDAQ |
Feb 20, 13:42
Disc Medicine EPS Diluted (Quarterly) : -1.772 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Boston Scientific Corp. | 0.4493 |
| Penumbra, Inc. | 1.167 |
| Emergent BioSolutions, Inc. | 0.9062 |
| Merck & Co., Inc. | 1.191 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -62.32M |
| Total Expenses (Quarterly) | 62.32M |
| Enterprise Value | 1.807B |
| Earnings Yield | -8.72% |
| Normalized Earnings Yield | -8.717 |